Viewing Study NCT03617367


Ignite Creation Date: 2025-12-25 @ 12:38 AM
Ignite Modification Date: 2026-02-24 @ 10:52 AM
Study NCT ID: NCT03617367
Status: COMPLETED
Last Update Posted: 2022-01-28
First Post: 2018-07-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Long-Term Safety and Efficacy of Repeat Treatments of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-OLS)
Sponsor: Revance Therapeutics, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 1720304
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View